Results 151 to 160 of about 34,560 (262)

Inflammatory Markers‐Based Surgical Pathological Complete Response Prediction After Neoadjuvant Immunotherapy Combined With Chemotherapy in Head and Neck Squamous Cell Carcinoma

World Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Objective To explore the predictive value of blood routine parameters for surgical pathological complete response (PCR) following neoadjuvant immunotherapy combined with chemotherapy (NICC) in patients with locally advanced head and neck squamous cell carcinoma (LAHNSCC).
Yu‐Dong Ning, Yi‐Xuan Song, Han Li, Yu‐Qin He, Shao‐Yan Liu   +4 more
wiley   +1 more source

Effects and mechanisms of mascRNA regulate the proliferation, migration and invasion of Laryngeal Squamous Cell Carcinoma in vitro. [PDF]

Braz J Otorhinolaryngol
Peng RJ, Zhang Z, Zhu S, Wu Y, Xu A, Li H, Ma S, Wang X.   +7 more
europepmc   +1 more source

Biomarkers Predictive of Immunotherapy Efficacy in Head and Neck Squamous Cell Carcinoma: Current Insights and Future Perspectives

World Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT With the approval of immunotherapies by regulatory bodies, head and neck squamous cell carcinoma (HNSCC) treatment has been revolutionized, and anti‐programmed cell death‐1 (anti‐PD‐1) agents are now the standard for platinum‐resistant recurrent/metastatic HNSCC.
Xiao‐Tong Yan, Zhao‐Hong An, Chang‐Ming An   +2 more
wiley   +1 more source

Clinicopathological features and prognostic analysis of 30 patients with laryngeal and hypopharyngeal adenoid cystic carcinoma: a single-center retrospective study. [PDF]

J Cancer Res Clin Oncol
Wang M, Zhou J, Ma T, Chen X.
europepmc   +1 more source

Neuroendocrine Carcinoma of the Head and Neck: A Two‐Decade Institutional Experience

World Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Objectives Primary neuroendocrine carcinoma (NEC) of the head and neck is rare (< 1% of cases) and aggressive, with poorly defined management strategies. This study evaluated clinical characteristics, treatment patterns, and survival outcomes in a single‐institution cohort, identifying factors associated with improved survival.
Micah K. Harris, Katie M. Carlson, Nathan Lu, Anthony Tang, Matthew E. Spector, Joshua D. Smith, Jessica H. Maxwell, Kevin J. Contrera, Seungwon Kim, Steven B. Chinn, Angela Mazul, Shaum S. Sridharan   +11 more
wiley   +1 more source

Synchronous malignant tumors of the larynx with various histogenesis: leiomyosarcoma and squamous cell carcinoma-A case report. [PDF]

J Med Case Rep
Cheremisina OV, Vtorushin SV, Vusik MV, Kulbakin DE, Naumov SS, Krakhmal NV.   +5 more
europepmc   +1 more source

HPV genotyping in head and neck cancer: Insights from a Colombian cohort. [PDF]

Braz J Otorhinolaryngol
Cruz-Romero SD, Ramos AE, Hakim JA, Cubillos AE, Baldión AM, Perdomo S, Baldión PA, Rodríguez-Urrego PA.   +7 more
europepmc   +1 more source

A Further Report upon a Case of Laryngeal Neoplasm [PDF]

Proceedings of the Royal Society of Medicine, 1914
openaire   +2 more sources

Risk Factors for Cutaneous Immune‐Related Adverse Events in the Japanese Population: A Retrospective Single‐Center Cohort Study

The Journal of Dermatology, EarlyView.
ABSTRACT Immune checkpoint inhibitor (ICI)‐driven alterations in the immune system can induce immune‐related adverse events (irAEs). Cutaneous irAEs are notable for being the most common and for their early onset; however, the risk factors underlying their development and severity remain unclear. In this study, we retrospectively analyzed 1224 Japanese
Tomoya Watanabe, Kohei Yamakawa, Miyu Kobayashi, Yusuke Saigusa, Yukie Yamaguchi   +4 more
wiley   +1 more source

Cervical tracheal resection, laryngectomy, total thyroidectomy and reconstructive stomaplasty for parastomal recurrence of a primary laryngeal malignant fibrous histiocytoma: a case report. [PDF]

J Cardiothorac Surg
Alexieva MS, Rangachev JD, Yankov GS.
europepmc   +1 more source